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Aptamers offer excellent potential for replacing antibodies for molecular recognition purposes 
however their performance can compromise with biological/environmental degradation being 
a particular problem. Molecularly imprinted polymers (MIPs) offer an alternative to biological 
materials and while these offer the robustness and ability to work in extreme environmental 
conditions, they often lack the same recognition performance. By slightly adapting the chemical 
structure of a DNA aptamer we have incorporated it for use as the recognition part of a MIP, 
thus creating an aptamer-MIP hybrid or aptaMIP. Here we have developed these for the 
detection of the target protein trypsin. The aptaMIP nanoparticles offer superior binding affinity 
over conventional MIP nanoparticles (nanoMIPs), with KD values of 6.8 × 10-9 (± 0.2 × 10-9) 
M and 12.3 × 10-9 (± 0.4 × 10-9) M for the aptaMIP and nanoMIP, respectively. The aptaMIP 
also outperforms the aptamer only (10.3 x 10-9 M). Good selectivity against other protein targets 
is observed. Using Surface Plasmon Resonance, the limit of detection for aptaMIP nanoparticles 
was two-fold lower (2nM) compared to the nanoMIP (4 nM).  Introduction of the aptamer as a 
“macro-monomer” into the MIP scaffold has beneficial effects and offers potential to improve 
this class of polymers significantly.   
 




The molecular recognition of large biomolecules such as nucleic acids, viruses and proteins, 
has become increasingly topical, especially with the aim of developing sensors for the detection 
of disease markers [1]. There are numerous options available to researchers. The most well-
known of these are antibodies which are well known for their use in analytical, diagnostic and 
therapeutic applications, due to their strong affinity to target molecules [2,3]. Though, while these 
have many beneficial traits, they have several disadvantages, including elevated cost, animal-
based sourcing, immunogenicity as well as limited shelf life and stability. As such, the drive 
for antibody replacements has led to interest in the development of suitable alternatives [4,5].  
One such alternative that has some significant commercial and academic interest is the aptamer. 
These small single-stranded RNA or DNA oligonucleotides [6] create internally folded 3D 
structures that are able to bind to molecules with great affinity and specificity through 
electrostatic interactions, hydrophobic interactions and their complementary three-dimensional 
shapes [7]. They have been shown to bind to a variety of molecular targets such as small 
molecules, proteins, nucleic acids as well as cells, tissues and organisms. Due to their relatively 
accessible synthetic process, flexibility in design and excellent molecular interaction profile, 
they have found use in in biotechnological and therapeutic applications [8,9]. They offer 
advantages over antibodies because they are readily produced by chemical synthesis; possess 
desirable storage properties and elicit little or no immunogenicity in therapeutic applications [6].  
Despite this, they do have some limitations, nominally around their thermal and chemical 
stability – the nature of the nucleic acid sequence leaves it open to degradation. 
Another molecular recognition alternative is that of molecular imprinting[10].  Molecularly 
imprinted polymers (MIPs) are gaining in popularity (in both commercial and academic 
settings) due to their performance characteristics including high affinity and selectivity, 
flexibility in applications, and resistance to extremes of temperature, pressure and pH variations 
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[11,12]. The process of generating a MIP involves the formation of selective sites in a polymer 
matrix. This usually involves the self-assembly of functional monomers around a template, 
through covalent and non-covalent bonds. The resultant template-monomer complexes are 
subsequently copolymerized with a suitable crosslinker. Removal of the template molecule 
from the polymer results in the formation of specific binding cavities, complementary in terms 
of structure and functionality to the template molecule [13-15].  For several years MIPs were 
limited by high levels of heterogeneity and by synthetic methods, but significant advances in 
molecular modelling and understanding of polymer chemistry have countered these issues.   
Imprinting of proteins is especially attractive, as the potential for non-biological molecular 
recognition can overcome some of the inherent issues of using biological materials 
(immunoresponse, enzymatic degradation etc.). They can also be targeted effectively for 
purpose, however there are some downsides as highlighted by Turner[10]. These include mass 
transfer, flexibility and stability of target, and heterogeneity when imprinting larger templates.  
Modern imprinting methods are able to overcome these. 
The development and enhancement of molecularly imprinted polymeric nanoparticles 
(nanoMIPs) have opened new perspectives in nanotechnology.  These have attracted a lot of 
attention due to their flexibility and analytical performance. These materials have the potential 
to transform traditional analytical methods in chemistry, biochemistry, environmental sciences 
and biomedical fields [16,17].  
The synthesis of hybrid materials, which exhibit the benefits of both aptamers and nanoMIPs, 
and in doing so, reduces the negative traits of both, is of great interest. From an aptamer point-
of-view, materials that maintain biological level recognition capabilities of an aptamer, while 
protecting the nucleic acid oligonucleotide from degradation would be highly sought after, 
while from a MIP viewpoint the use of a specific targeted “monomer” which can reduce 
heterogeneity would improve the performed of this valuable class of artificial recognition 
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material. Several groups have considered this as discussed in an excellent short review by 
Zhang and Liu [18].  
In example, Spivak and team used Acrydite-linked small aptamers in a hydrogel to act as a 
biomolecular-responsive capture agent. When the template was present the gel “shrunk” 
signifying binding [19].   Jolly et al (2016) used a 5’-thiolated sequence, bound to gold electrode. 
Around the aptamer-template complex a polydopamine scaffold was formed [20]. With 
admirable detection limits they showed that the fixed sequence with its polymer offered 3-fold 
improvement of affinity when compared to the aptamer alone.   
This work mirrors the 2014 findings of the Turner group who created the first true aptaMIPs, 
where the aptamer was used as a “macro-monomer”. Here the thymine bases in a sequence were 
replaced by a carboxy-dT (Figure 1).  The sequence specific for cocaine was then used in the 
creation of nanoMIPs which already exhibit exceptional binding capabilities. Not only did the 
binding affinity when compared to the free aptamer increase by three orders of magnitude, the 
aptaMIP performance was an improvement on the plain nanoMIP. This was hypothesised to be 
due to the use of multiple-point linkages holding the aptamer into an optimal binding 
conformation.  This multiple-linker strategy has also been employed by Allabush who used it 
to incorporate an aptamer into a gel for protein electrophoresis [21]. Incorporation of an aptamer 
into a hybrid system in this manner also has shown to increase stability [22], and counter any 
thermal or enzymatic (nuclease) degradation that is often seen with aptamers on their own [23,24]. 




Figure 1. Replacement thymine base. Modified Carboxy-dT-CE Phosphoramidite (T*). 
The aim of this study is to further explore the development of hybrid-MIP nanoparticles 
(aptaMIP NP) for a protein target (trypsin). Prior to this paper, the technique had only been 
demonstrated using short nucleic acid sequences [25] or small molecules [22] as discussed in the 
previous paragraph.  Using similar chemistry as these papers, we now employ a superior 
analytical technique, (that of surface plasmon resonance (SPR), which offers greater sensitivity 
when compared to the microgravimetric measurements previously used) to compare the 
performance of these aptaMIPs against MIP NPs, and the published data of the free aptamer to 
determine any improvement in affinity/specificity. Selectivity of the hybrid is also examined 
with reloading of a non-target proteins (lysozyme and bovine serum albumin). 
Experimental Section 
Materials and Equipment: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 3-
aminopropyltrimethyloxy-silane (APTMS), acrylic acid (AAc), ammonium persulfate (APS), 
dipotassium phosphate, bovine serum albumin (BSA), disodium phosphate, ethanolamine, 
ethylenediaminetetraacetic acid (EDTA), glass beads, glutaraldehyde (GA), glycine, lysozyme 
N,N’-methylenebisacrylamide (BIS), N-hydroxysuccinimide (NHS), N-isopropylacrylamide 
(NIPAm), N-tert-butylacrylamide (TBAm), sodium dodecyl sulphate (SDS), Tween 20, 
tetramethylethyldiamide (TEMED), and trypsin were all purchased and used without 
purification from Sigma-Aldrich, Poole, Dorset, UK. Acetone, acetonitrile (dry), methanol, 
potassium chloride, and sodium hydroxide were all purchased and used without purification 
from Fisher Scientific UK Ltd, Loughborough, UK.  Carboxy-dT-CE phosphonamidite were 
purchased and used without purification from LGC Link, Bellshill, Lanarkshire, UK. Double-
distilled water was used for the analysis. All chemicals and solvents were analytical or high-
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performance liquid chromatography (HPLC) grade and were used without further purification. 
Trypsin aptamer sequence was selected for use based on this literature [26,27].  
Synthesis of Polymerizable Aptamer Sequence: The trypsin aptamer (5’-
GACAGCCACATGTACTGAGGTAGACTTGGGTGGGGGACAG-3’) (where T in 
bold represents the insertion of a polymerizable base T*) was synthesized under standard 
conditions at 10-µmol scale on an AKTA Oligopilot 10 oligonucleotide synthesizer. The 
oligomers were briefly treated with diethylamine, then deprotected and released from the 
support by treatment with concentrated aqueous NH3 at 55 °C for 16 hours. The solutions were 
concentrated to dryness, resuspended in water, and desalted using NAP-10 columns (GE 
Healthcare). Oligonucleotide masses were verified using an Agilent 6530 QTOF LC/MS 
system.  
Preparation of Trypsin-Derivatized Glass Beads as Affinity Media: Glass beads (30 g, 75 µm 
diameter, Supelco) were activated by boiling in 4 M NaOH (24 mL) for 15 minutes, then 
washed thoroughly with double-distilled water (eight times with 100 mL, for 30 g of beads), 
until the pH of the water/bead solution is around 7. Rinsed twice with acetone (100 mL) and 
dried at 80 °C for 3 hours. They were then incubated in a 12 mL solution of APTMS (3%, v/v) 
in anhydrous toluene overnight at 60 °C. After incubation the glass beads were washed with 8 
volumes (100 mL) of acetone, followed by 2 volumes (100 mL) of methanol and dried in an 
oven at 150 °C for 30 mins. The amine-functionalized beads were then incubated in a 7% (v/v) 
glutaraldehyde solution (0.5 mL of solution per gram of beads) for 2 hours at room temperature. 
Trypsin (7.5 mg at 0.5 mg/mL) was introduced to the GA-modified beads in 15 mL phosphate-
buffered saline (PBS, 10 mM) pH 7.4, with the solution being left to incubate at room 
temperature overnight, sealed under nitrogen. The trypsin derivatized beads were washed 
thoroughly with doubled-distilled water and dried under vacuum. After this step, the glass beads 
were used straight away for the synthesis of the imprinted nanoparticles without further storage. 
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Solid-Phase Synthesis of Trypsin Imprinted nanoMIPs: A polymerisation mixture consisting of 
NIPAm (20 mg). BIS (1 mg), and AA (2.2 µL) in 49 mL of double distilled water, was produced. 
In a separated vial 17 mg of TBAm was dissolved in 250 µL of ethanol and this was added to 
the previous solution with the other compounds. Finally, double distilled water was added to 
the flask with the polymerisation mixture to adjust the total volume to 50 mL. This solution was 
degassed under vacuum, while sonicating for 10 minutes. Following this, the polymerisation 
mixture was bubbled for 20 minutes with a slow stream of N2.  
Meanwhile, 30 g of the template-derivatized glass beads was transferred into a 100 mL sealable 
bottle and degassed by purging with N2 for 10 minutes. Next, the 50 mL of degassed solution 
of monomers was poured onto the glass beads, followed by the rapid addition of 12.5 µL of 
TEMED and 15 mg of APS dissolved in 250 µL of double distilled water, to allow for 
polymerization to be initiated. Everything was gently agitated via swirl motion and left to 
polymerise for 1 hour at room temperature, gently swirling from time to time. Note it is 
important that this is gentle to limit risk of abrasion. After the synthesis, the beads were filtered 
through a 11 µm filter paper, using gravity filtration and then the beads were washed 8 x 30 mL 
of water at ambient temperature in order to remove the impurities, unreacted monomers and 
low-affinity nanoMIPs. To elute high affinity nanoMIPs, the beads were heated in 40 mL of 
water at 60 °C, then filtered again using gravity filtration, the beads were then further washed 
with volumes of 20 mL of water at 60 °C, until approximately 100 mL of the eluted 
nanoparticles in water was collected. The solutions of all nanoMIPs were stored in at 4 °C until 
measurements were taken. 
Solid-Phase Synthesis of Trypsin Imprinted Hybrid-MIPs: In different vials, a solution of 1.74 
µmol of the aptamer in 10 mL of double distilled water was prepared and a polymerisation 
mixture consisting of NIPAm (20 mg). BIS (1 mg), and AA (2.2 µL) in 39 mL of double 
distilled water was prepared. In a separated vial 17 mg of TBAm was dissolved in 250 µL of 
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ethanol and this was added to the previous solution with the other compounds. Finally, double 
distilled water was added to the flask with the polymerisation mixture to adjust the total volume 
to 40 mL. This solution was degassed under vacuum, while sonicating for 10 minutes. 
Following this, the polymerisation mixture was bubbled for 20 minutes with a slow stream of 
N2.  
Meanwhile 30 g of the template-derivatized glass beads was transferred into a 100 mL sealable 
bottle and degassed by purging with N2 for 10 minutes. The aptamer solution was poured onto 
the glass beads and left to incubate at room temperature for 10 minutes, with gentle swirling. 
Next, the 40 mL of degassed solution of monomers was poured onto the glass beads, followed 
by the rapid addition of 12.5 µL of TEMED and 15 mg of APS dissolved in 250 µL of double 
distilled water, to allow for polymerization to be initiated. Everything was swirled very gently 
and left to polymerise for 1 hour at room temperature, gently swirling from time to time. After 
the synthesis, the beads were filtered through a 11 µm filter paper, using gravity filtration and 
then the beads were washed 8 x 30 mL of water at ambient temperature in order to remove the 
impurities, unreacted monomers and low-affinity AptaMIP NPs. To elute high affinity 
AptaMIP NPs, the beads were heated in 40 mL of water at 60 °C, then filtered again using 
gravity filtration, the beads were then washed with volumes of 20 mL of water at 60 °C, until 
approximately 100 mL of the eluted nanoparticles in water was collected. The solutions of all 
AptaMIP NPs were stored in at 4 °C until measurements were taken. 
 
Characterization of Nanoparticles: Effective hydrodynamic diameters (dh) of the particles were 
determined by dynamic light scattering (DLS) with a NanoBrook Omni spectrometer 
(Brookhaven, United States) at 25 °C. Particle size was determined using Particle Solutions 
(v2.6) software with a total of 5 measurements per sample and a time interval of 10 seconds 
between measurements.  
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The shape and surface topography of the nanoparticles were determined by using Carl Zeiss 
SEM EVO High Definition 15 Scanning Electron Microscope (Carl Zeiss, Germany) operating 
at 15 kV. The samples were mounted on a metal stub with double-side adhesive tape and gold-
coated under vacuum in an argon atmosphere prior to observation. 
Concentration of the nanoparticle solution was calculated by take 3 mL of the solution and 
evaporated to dryness at 60 °C. The mass of the dried particles was then measured, divided by 
three to reveal the concentration in µg mL-1. This was repeated five times. 
Surface plasmon resonance (SPR) experiments were performed in order to evaluate the affinity 
and specificity of the imprinted nanoparticles for the different targets. Measurements were 
carried out using a Reichert 2SPR system. 
Immobilisation of the SPR Sensor Surface: Carboxymethyl Dextran Hydrogel coated Au chips, 
purchased from Reichert Technologies (Buffalo, USA) were installed onto a Reichert 2SPR 
following the manufacturer’s instructions. The sensor surface was then preconditioned by 
running PBST (PBS pH 7.4 and 0.01 % Tween 20) at 10 µL min-1 until a stable baseline was 
obtained. The flow rate of 10 µL was maintained throughout the immobilisation process. In 
order to activate carboxy groups on the surface of the sensor chip, a fresh preparation of 40 mg 
EDC and 10 mg NHS dissolved in 1 mL water was injected onto the sensor chip surface for 6 
minutes. To the activated surface 300 µg of the aptaMIP or nanoMIP dissolved in 1 mL of the 
running buffer (PBST) and 10 mM sodium acetate (820 µg mL-1), (this is added in order to 
activate the NH functional groups within the MIP NP, this allows for the MIP NP to bind to the 
SPR chip surface), using NHS EDC coupling, the aptaMIP or nanoMIP solution was injected 
only to the left channel of the surface for 1 minute (multiple NH2 functionality is available from 
the composition of the polymer scaffold).  Finally, quenching solution (1 M ethanolamine, pH 
8.5) was injected for 8 min to deactivate carboxyl groups and to wash away the unbound 
nanoMIP. A continuous flow of running buffer (PBST) at 10 µL min-1 was maintained after the 
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completion of the aptaMIP or nanoMIP immobilisation. SPR assays were carried out after a 
stable baseline was achieved. The left channel is the working channel while the right channel 
is the reference. 
Kinetic Analysis Using SPR: Kinetic analysis was initiated by injection of the running buffer 
PBST (blank) onto the aptaMIP/nanoMIP immobilised sensor surface for 2 min, followed by 
PBST for 5 min. The binding kinetics of an individual aptaMIP/nanoMIP to the selected target 
protein (trypsin) was determined from serial dilutions (five concentrations, 50-3.125 µM) of 
trypsin under study. Each dilution was injected for 2 min (association) followed by PBST for 5 
min (dissociation). After dissociation, the target protein was removed from the immobilized 
surface by injecting regeneration buffer (10 mM Glycine-HCl, pH 2) for 1 min followed by 
PBST for 1 min. The same procedures were repeated for the remaining four dilutions of the 
protein. After the analyses were completed, signals from left channel were subtracted from 
signals from their respective reference channel (the right channel). Selectivity for the 
aptaMIP/nanoMIP particles was investigated by repeating the SPR kinetic analysis, but using 
two non-target proteins (lysozyme and BSA) at the same concentrations instead. All analyses 
were carried out at 25 °C. 
The SPR responses from five concentrations of the target protein were fitted to a 1:1 bio-
interaction model (Langmuir fit model) utilizing TraceDrawer Software. Association rate 
constant (ka), dissociation rate constant (kd), and maximum binding (Bmax) were fitted globally, 
whereas the BI signal was fitted locally. The equilibrium dissociation constant (KD) was 
calculated from the ratio kd/ka. A SPR sensorgram calibration was created using a concentration 
range of 0.001-1 µM and was used to calculate a lower limit of detection (LOD).  
Results and Discussion 
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Preparation and Characterisation: Here we present a novel strategy for the preparation of 
soluble aptamer-MIP nanoparticle hybrid (aptaMIP) for the protein trypsin. The procedure of 
the solid-phase synthesis of trypsin-specific aptaMIP NPs was adapted from the protocols of 
Safaryan and Poma [22,28]. The target protein is attached to a solid support, with the aptaMIP 
NPs then being synthesized on to the solid support, which are easily released, thanks to their 
thermoresponsive properties. The strategy is schematically presented in Figure 2. The glass 
beads (diameter 75µm) were first silanized with an aminosilane (APTMS) and the protein 
(trypsin) was attached using glutaraldehyde as a coupling agent. The polymerizable aptamer 
was then incubated with the protein derivatized glass beads to form a protein-aptamer complex, 
with polymerization conducted around the immobilized complex. N-Isopropylacrylamide 
(NIPAm) was used as the major component in the polymer recipe, which enables 
thermoresponsive properties in the resultant NPs. Corresponding plain MIP NPs were produced, 
for comparison, using the same method, but with the absence of the polymerizable aptamer.  
These will be known as aptaMIP and nanoMIP forthwith. 
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Figure 2. Schematic representation of the solid-phase synthesis of aptaMIP NPs. Red circle 
indicates the modified polymerizable base. Green Star representative of trypsin protein. I: 
Synthesis of modified aptamer sequence.  II: Complexation of aptamer with protein target 
attached to inert solid phase. III: Addition of polymer scaffold components, polymerisation and 
formation of polymer scaffold via TEMED initiated reaction; IV: Thermal (60 °C) release of 
nanoparticle bearing aptamer sequence. Note: Positive control nanoMIPs made using same 
solid-phase method as shown [29], but without the aptamer present. 
The aptamer (5’-GACAGCCACATGTACTGAGGTAGACTTGGGTGGGGGACAG-
3’) specific for trypsin was produced with a modified with a carboxy polymerizable functional 
group (shown in Figure 1). These modified bases are shown in bold, with in the sequence. The 
aptamer is modified with six anchoring points, where previous studies [22] have shown that 
multiple anchoring points provide the best rebinding performance. Given that multiple-linkers 
sites were shown to be beneficial we did not elect to study single-point linkers at 5’ or 3’ ends. 
This is in line with prior work,[22] which showed that a single modification at either end was not 
effective in fixing the aptamer into the polymer in an effective manner.  We elected to not put 
two modifications together position 26-27) as it is not clear what effect this might have on the 
oligo structure. Likewise, having two polymerizable modifications next to each other may 
hinder reactivity.  
The concentration of the aptaMIP and nanoMIP nanoparticle solutions were calculated to be 58 
± 10 µg mL-1 and 114 ± 18 µg mL-1, respectively. In order to determine this concentration, 3 
mL of sample was incubated at 60 °C until dry, particle mass was measured (6-point balance) 
and concentration (per mL) was calculated. The aptaMIP and nanoMIP materials were then 
analysed by dynamic light scattering (DLS) and scanning electron microscopy (SEM). They 
showed a diameter of 219 ± 8 nm and 107 ± 6 nm at 25 °C, respectively (see Figure S1 and 
S2, ESI, for particle distribution and the SEM images).  The differences in size is interesting 
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and has been noted in prior studies. Given that the polymerisation conditions (and length of 
reaction) are the same, we might expect the sizes to be similar, however this data suggest there 
may be another factor. One potential hypothesis is that the aptamer in its optimal binding 
conformation interacting with the template during pre-complexation offers a superior 
nucleation site when compared to the random orientation of the monomers in the nanoMIP 
reaction. This is under investigation.  
Binding performance of proteins to synthesised imprinted nanoparticles: The nanoparticles 
were then dissolved into the running buffer solution, with the addition of sodium acetate, for 
SPR analysis. A carboxymethyl dextran hydrogel-coated Au chip was activated using NHS and 
EDC, followed by the addition of the dissolved NP. The functionality on the polymer scaffold 
reacts allowing the nanoparticles to covalently link to the chip surface.  Finally, a quenching 
solution of ethanolamine was used to deactivate the carboxyl group and wash away any 
unbound NP.  
The sensorgrams of the interactions of the five different concentrations of the same target 
protein (trypsin) captured by the aptaMIP (Figure 3A) and nanoMIP (Figure 3B), immobilised 
on the sensor surface. 0.01% Tween20 was added to the running buffer to reduce non-specific 
binding.  
To study cross-reactivity and non-specific binding, non-target proteins (Lysozyme and BSA) 
were also investigated. The binding for lysozyme shown in Figure 3C (aptaMIP) and Figure 
3D (nanoMIP) and the binding for BSA shown in Figure 3E (aptaMIP) and Figure 3F 
(nanoMIP).  Experiments were repeated in triplicate and the SPR curves were fitted to a 1:1 
interaction model. The overall equilibrium dissociation constant (KD) of the aptaMIP and 
nanoMIP towards these proteins were determined.  This is summarised in Table 1.  




Figure 3. Representative SPR sensorgrams of molecular interactions of various nanoparticles 
immobilised on carboxymethyl dextran hydrogel coated Au chips, to solutions containing five 
concentrations of protein (trypsin, lysozyme or BSA, with lysozyme or BSA as negative 
controls).  (A) trypsin binding to trypsin-imprinted aptaMIPs; (B) trypsin vs. trypsin-imprinted 
nanoMIPs; (C) lysozyme binding to trypsin-imprinted aptaMIPs; and (D) lysozyme binding to 
trypsin-imprinted nanoMIPs. (E) BSA binding to trypsin-imprinted aptaMIPs; and (F) BSA 
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Table 1. Calculated equilibrium dissociation constant (KD) of imprinted materials. 
 KD (M) 
Trypsin Lysozyme BSA 
aptaMIP 6.8 × 10-9 (± 0.2 × 10-9) 5.4 × 10-6 (± 0.4 × 10-6) 7.6 × 10-6 (± 1.1 × 10-6) 
nanoMIP 12.3 × 10-9 (± 0.4 × 10-9) 3.2 × 10-6 (± 0.5 × 10-6) 6.3 × 10-6 (± 0.8 × 10-6) 
 
The method to produce the nanoMIP materials was adapted from the work of Safaryan, which 
also successfully produced nanoMIPs for trypsin with an estimated KD value of 15.8 nM [28]. 
The nanoMIPs produced within this study have a calculated KD valued of 12.3 nM (Table 1).  
These two are comparable and as such confirm the validity of the synthetic technique. The 
nanoMIP, without the addition of a specific monomer, offers binding and recognition towards 
the target protein [28] comparable to published antibodies and the free aptamer that was used in 
this experiment [26,27]. 
The KD of the interaction between trypsin and the trypsin-specific aptaMIP hybrids has been 
calculated at 6.8 nM (Table 1). The fixing of the aptamer into the scaffold of the MIP improves 
the KD two-fold (6.8 vs 12.3 nM), when compared to the nanoMIP, made in the same way but 
without the macro-monomer. While this is not as dramatic an increase as observed in prior work 
(namely the 2000x increase observed in Poma’s work [22], the initial aptamer selected here 
already had superior affinity properties (nM affinity compared to µM in the cocaine aptamer in 
the prior Poma work). This validates the approach used and supports the observation that the 
addition of a pre-targeted macro-monomer improves performance. The ratio of relative signal 
strengths (Figure 3) shows the aptaMIP offers approximately double the signal upon binding 
compared to the nanoMIP.  This is relative to the ratio of KD aptaMIP/KD nanoMIP which is 1.80. The 
comparison is expected as it suggests that the aptaMIP consistently binds more material at a 
given concentration, supporting it having greater affinity. 
Work by Xiao showed this trypsin aptamer to have the lowest calculated dissociation constant 
(KD) value of 10.3 nM and has been used further by Wang for the immobilization of trypsin 
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onto modified silica particles [26,27]. Mirroring the prior work by Poma, the suspension of the 
aptamer in the polymeric scaffold, through locking it into an optimal binding conformation, has 
increased the aptamer recognition performance. It is further evidence that fixing the aptamer in 
place in an optimal binding conformation increases performance through reducing entropic 
effects – the interaction is under thermodynamic control and by fixing less energy is lost to 
flexing and reorientation of the aptamer. In essence it is shaped exactly as needed for optimal 
binding.   
Also, this aptamer has a sequence of 5’TTGGGTGGGGG-3’, which has the potential for 
transformation into a G-quartet, whereby the G-quartet can play a pivotal role in the binding 
mechanism of aptamers [30-32]. This is interesting given that two modifications were placed 
within this motif which suggests that complex secondary structure can be modified without 
disruption of binding.  
In order to evaluate the ability of the generated materials to discriminate between trypsin and 
other proteins, both the aptaMIP and nanoMIP were challenged with the non-imprinted proteins 
lysozyme, chosen due to the approximate size and hydrophobic solvent accessible surface areas 
(SASA) and BSA, chosen as it is a representative protein in the same matrix that trypsin may 
be found. SPR analysis, shown in Figures 3C, 3D, 3E and 3F reveals that there is some binding 
of lysozyme and BSA to both the materials, but with vastly reduced affinity (KD values of 5.4, 
3.2, 7.6 and 6.3 µM, respectively). This demonstrates that both systems, as expected, are 
selective for the template. The KD value difference between the lysozyme or BSA binding in 
the aptaMIP and nanoMIP particles is similar, and the decrease observed also, further 
suggesting that any binding of lysozyme or BSA to the NPs is non-specific. The observed 
relative signal is comparable as well suggesting no differences in affinity. In summary, the 
nanoMIP has less affinity for the target template, but higher cross-reactivity when compared to 
the aptaMIP, suggesting that the aptaMIP is the superior material. 
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The aptaMIP and nanoMIP detection limits where investigated in order to determine the lower 
limit of detection (LOD) for both the aptaMIP and nanoMIP particles. SPR analysis was 
conducted using a concentration range of 0.001-1 µM and the curves are shown in Figure 4. 
Eight different concentrations of the same target protein (trypsin) were captured by the aptaMIP 
(Figure 4A) and nanoMIP (Figure 4B), which were immobilised on the sensor surface. A 
0.01% Tween20 was added to the running buffer to reduce non-specific binding. Using the 
maximum signal (µRIU) from the fitted curves, concentration calibrations were plotted. This 


















Figure 4. Elucidation of limit of detection for SPE sensor. Relative signal vs concentration (A) 
trypsin binding to trypsin-imprinted aptaMIPs concentration calibration (insert showing 
linearity of the low concentration range); (B) trypsin binding to trypsin-imprinted nanoMIPs 
concentration calibration (insert showing linearity of the low concentration range).   
The aptaMIP produced a lower LOD estimate of 2.4 nM, while the nanoMIP produced a lower 
LOD estimate of 4.1 nM. These estimates show that the identical sensor surfaces coated with 
aptaMIP particles are able to detect lower concentrations of the target molecule, compared with 
the nanoMIP. The ratio LODnanoMIP/LODaptaMIP is 1.70 and is comparable to the KD aptaMIP/KD 
nanoMIP of 1.80 (Table 1). It should be noted the obtained signal here is relative, and the scale is 
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not comparable to Figure 3. This is an artefact of the software and experimental setup. Given 
the synthetic protocol is the same, and results are replicable, this suggests the aptaMIP particles 
have superior binding affinities over the nanoMIP which further supports that the addition of 
the “macro-monomer” aptamer is beneficial to the imprinting process, improving not just 
affinity and specificity (Table 1) in comparative applications.  Therefore, they are demonstrably 
superior materials in the sensor applications. While these data differences may look small, in 
analytical terms a doubling of performance is significant and can be the difference between a 
positive or negative result.  This is also in the magnitude observed by Jolly [20].   
Overall the data presented here, further supports the use of a targeted predetermined “macro-
monomer” in the synthesis of imprinted materials. It agrees with prior data, from this group and 
others, that the hybrid approach offers a good opportunity to improve MIP performance. 
Conclusion 
By combining bio-recognition oligonucleotides (aptamers) with molecularly imprinted 
materials, we are able to demonstrate a hybrid material that exhibit superior performance to its 
components – a material that is greater than the sum of its parts. This was observed both in 
terms of their affinity towards the template protein, but also in cross-reactivity studies. The 
synthesis of these materials is relatively straightforward using an existing solid-phase synthesis 
methodology. The gentle polymerization conditions allow for the aptamer monomers and 
protein template to retain their stability, eradicating any potential denaturation during the 
polymerization process. These hybrid systems targeting proteins could lead the way for 
potential sensor applications as demonstrated in this communication. Given the improvements 
observed here these materials could have significant potential in therapeutic applications. 
Multiple opportunities exist with a variety of targets and alterations to the chemistry involved. 
Potential changes to the running buffer (increase in surfactant) or longer equilibrium periods 
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may further reduce cross-reactivity, and are under investigation.  We are currently exploring 
position and number of linkers to elucidate what is required to maintain and effective 
incorporation and imprint.  We are also exploring the potential of using these materials in sensor 
applications.  
Several questions still remain with these nascent hybrids, including that of nucleation around 
the aptamer appearing to alter the polymerisation reaction kinetics; and how to further reduce 
non-specific binding, but the authors expect in time these questions will be answered.  What is 
clear is that there is a future of these hybrid materials in the fields of both imprinted polymers 
and aptamers. 
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Figure 1. Replacement thymine base. Modified Carboxy-dT-CE Phosphoramidite (T*). 
 
 
Figure 2. Schematic representation of the solid-phase synthesis of aptaMIP NPs. Red circle 
indicates the modified polymerizable base. Green Star representative of trypsin protein. I: 
Synthesis of modified aptamer sequence.  II: Complexation of aptamer with protein target 
attached to inert solid phase. III: Addition of polymer scaffold components, polymerisation and 
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formation of polymer scaffold via TEMED initiated reaction; IV: Thermal (60 °C) release of 
nanoparticle bearing aptamer sequence. Note: protein template is left affixed to support for re-
use. Note: Positive control nanoMIPs made using same solid-phase method as shown (29), but 
without the aptamer present. 
 
Figure 3. Representative SPR sensorgrams of molecular interactions of various nanoparticles 
immobilised on carboxymethyl dextran hydrogel coated Au chips, to solutions containing five 
concentrations of protein (trypsin, lysozyme or BSA, with lysozyme or BSA as negative 




































































































































































     
24 
 
imprinted nanoMIPs; (C) lysozyme binding to trypsin-imprinted aptaMIPs; and (D) lysozyme 
binding to trypsin-imprinted nanoMIPs. (E) BSA binding to trypsin-imprinted aptaMIPs; and 
(F) BSA binding to trypsin-imprinted nanoMIPs. 
 
 
Figure 4. Elucidation of limit of detection for SPE sensor. Relative signal vs concentration (A) 
trypsin binding to trypsin-imprinted aptaMIPs concentration calibration (insert showing 
linearity of the low concentration range); (B) trypsin binding to trypsin-imprinted nanoMIPs 
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Table 1. Calculated equilibrium dissociation constant (KD) of imprinted materials. 
 KD (M) 
Trypsin Lysozyme BSA 
aptaMIP 6.8 × 10-9 (± 0.2 × 10-9) 5.4 × 10-6 (± 0.4 × 10-6) 7.6 × 10-6 (± 1.1 × 10-6) 
nanoMIP 12.3 × 10-9 (± 0.4 × 10-9) 3.2 × 10-6 (± 0.5 × 10-6) 6.3 × 10-6 (± 0.8 × 10-6) 
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The development of a strategy that uses modified aptamers as the recognition elements of 
molecularly imprinted polymeric nanoparticles (AptaMIP NPs) is presented. The introduction 
of this modified “aptamer monomer” leads to an increase in the affinity of the produced MIP 
NPs, without any alteration to their physical properties such as size, shape, or dispersibility. 
 
Keyword Aptamers, Molecularly Imprinted Polymers, Nanoparticles, Protein, Solid-Phase 
Synthesis. 
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Figure S1. Particle size distribution for the trypsin-specific MIP NPs (A) and trypsin-specific 
AptaMIP NPs (B) 
 
A B 




Figure S2. SEM images of (A) trypsin-specific MIP NPs and (B) trypsin-specific AptaMIP 
NPs. 
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